JP2000355533A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000355533A5 JP2000355533A5 JP1999164146A JP16414699A JP2000355533A5 JP 2000355533 A5 JP2000355533 A5 JP 2000355533A5 JP 1999164146 A JP1999164146 A JP 1999164146A JP 16414699 A JP16414699 A JP 16414699A JP 2000355533 A5 JP2000355533 A5 JP 2000355533A5
- Authority
- JP
- Japan
- Prior art keywords
- ascorbic acid
- prevention
- glycosyl
- patent application
- unexamined patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005070 ascorbic acid Drugs 0.000 description 7
- CIWBSHSKHKDKBQ-DUZGATOHSA-N (+)-Ascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 5
- 235000000069 L-ascorbic acid Nutrition 0.000 description 5
- 239000002211 L-ascorbic acid Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 230000002265 prevention Effects 0.000 description 3
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000002087 whitening Effects 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010034754 Petechiae Diseases 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening Effects 0.000 description 1
Description
前記ビタミン類の内、L−アスコルビン酸は、皮膚の美白化および白色化、皮膚の虚弱化予防、点状出血予防、斑状出血予防、血行促進などの作用を有することから、本発明に於いては好適に用いることができる。L−アスコルビン酸としては、本発明の浴用製品に使用できるものであれば、その由来、性状は問わない。天然または有機合成により得られるL−アスコルビン酸は勿論のこと、特公昭48−38158号公報、特公昭58−5920号公報、特開昭58−198498号公報、特開平3−139288号公報、特開平3−135992号公報、および特願平10−101855号明細書(特開平11−286497号公報)などに開示されているL−アスコルビン酸誘導体が使用できる。これらL−アスコルビン酸誘導体の内、特開平3−139288号公報、および特開平3−135992号公報に開示されたα−グリコシル アスコルビン酸は、安定型L−アスコルビン酸として有利に使用できる。α−グリコシル アスコルビン酸は、L−アスコルビン酸と比べ、耐熱性、耐光性に優れ、水への溶解度も高いとの利点を有していることから、本発明の浴用製品に好適に使用できる。 Among the above-mentioned vitamins, L-ascorbic acid has effects such as skin whitening and whitening, skin weakening prevention, petechiae prevention, ecchymosis prevention, and blood circulation promotion. Can be suitably used. As long as L-ascorbic acid can be used in the bath product of the present invention, its origin and properties are not limited. L-ascorbic acid obtained by natural or organic synthesis, as well as JP-B-48-38158, JP-B-58-5920, JP-A-58-198498, JP-A-3-139288, L-ascorbic acid derivatives disclosed in Japanese Unexamined Patent Publication No. Hei. 3-135,992 and Japanese Patent Application No. 10-101855 (Japanese Unexamined Patent Application Publication No. 11-286497) can be used. Among these L-ascorbic acid derivatives, α-glycosyl ascorbic acid disclosed in JP-A-3-139288 and JP-A-3-135998 can be advantageously used as stable L-ascorbic acid. α-Glycosyl ascorbic acid has excellent heat resistance, light resistance and high solubility in water, as compared with L-ascorbic acid, and thus can be suitably used for the bath product of the present invention.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11164146A JP2000355533A (en) | 1999-06-10 | 1999-06-10 | Product for bathing use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11164146A JP2000355533A (en) | 1999-06-10 | 1999-06-10 | Product for bathing use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000355533A JP2000355533A (en) | 2000-12-26 |
JP2000355533A5 true JP2000355533A5 (en) | 2006-06-29 |
Family
ID=15787630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11164146A Pending JP2000355533A (en) | 1999-06-10 | 1999-06-10 | Product for bathing use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2000355533A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4410971B2 (en) * | 2002-02-08 | 2010-02-10 | 小川香料株式会社 | Naphthol glycoside and whitening external preparation composition containing the same |
JP2006249026A (en) * | 2005-03-11 | 2006-09-21 | Kanebo Ltd | Bathing agent of foamed molded product, composition for bathing agent of foamed molded product and bathing method |
JP2006249027A (en) * | 2005-03-11 | 2006-09-21 | Kanebo Ltd | Cosmetic of foamed molded product, cosmetic composition and makeup method |
KR101884653B1 (en) * | 2016-08-17 | 2018-08-03 | 김민수 | A method for manufacturing a multiple-use bath preparation using natural ingredients, and the bath preparation manufactured the method |
JP7227707B2 (en) * | 2018-06-29 | 2023-02-22 | アース製薬株式会社 | Volatilization method of volatile components |
JP7351515B2 (en) * | 2019-10-24 | 2023-09-27 | 株式会社ウエノフードテクノ | Powder quality preservation agent and quality preservation method |
-
1999
- 1999-06-10 JP JP11164146A patent/JP2000355533A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1041072T3 (en) | Dioxocyclopentylhydroxamic acids | |
BR0113663A (en) | Pectin Film Compositions | |
DE60220182D1 (en) | ALCOHOL-FREE BEVERAGE SET | |
ATE487472T1 (en) | NON-GELATINAOUS CAPSULES | |
CA2378369A1 (en) | Small molecules useful in the treatment of inflammatory disease | |
NO20003698L (en) | Oral compositions | |
NO921609D0 (en) | SULPHONAMIDS AND THEIR MEDICAL USE | |
EP2767291A3 (en) | Treatment of glycogen storage disease type II | |
CY1108770T1 (en) | NEW PRODUCTS OF INDOLIUM AND USE AS MEDICINES | |
JP2002506648A5 (en) | ||
JP2000355533A5 (en) | ||
NO20030802D0 (en) | Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, processes for their preparation and preparations containing the same | |
ATE267816T1 (en) | TAN-1057 DERIVATIVES | |
ATE254457T1 (en) | AQUEOUS LIQUID PHARMACEUTICAL COMPOSITION CONTAINING A BENZOPYRANE DERIVATIVE AS THE MAIN INGREDIENT | |
NO20003108L (en) | Use of melatonin energetic ligands in the preparation of pharmaceutical compositions | |
DE60108354D1 (en) | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions | |
FR2860234B1 (en) | NEW THIOXYLOSE DERIVATIVES 666 | |
ATE241640T1 (en) | FUSIDIC ACID DERIVATIVES | |
JP2000319390A5 (en) | ||
ATE153032T1 (en) | CYCLIC ANGIOPEPTIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
EE200300433A (en) | Caloporoside derivatives, their preparation and use as medicaments, medicaments containing them and strain ST001714 of the microorganism Gloeoporus dichrous (Fr.:Fr.) (DSM 13784) | |
WO2001022976A3 (en) | Combination of a statin and ex-vivo treated blood for treating artheroclerosis | |
TH43195A3 (en) | Sterical Hinderamine Compounds | |
TH43536EX (en) | CD rack | |
TH43535EX (en) | CD rack |